Correction: Filippone et al. Inhibition of LRRK2 Attenuates Depression-Related Symptoms in Mice with Moderate Traumatic Brain Injury. Cells 2023, 12, 1040

Key Points

• To examine the effects of LRRK2 inhibition on depression-related symptoms in a mouse model of moderate traumatic brain injury.
• Utilized a mouse model of moderate traumatic brain injury.
• Administered LRRK2 inhibitors to evaluate their effects on depression-like behaviors.
• Conducted behavioral tests to assess symptoms post-treatment.
• Inhibition of LRRK2 significantly reduced depression-like behaviors in mice, with improvements in mood-related tests.
• Behavioral assessments indicated a decrease in anxiety levels and an increase in activity metrics post-treatment.